Pilot trial of 1% pimecrolimus cream in the treatment of seborrheic dermatitis in African American adults with associated hypopigmentation.

@article{High2006PilotTO,
  title={Pilot trial of 1% pimecrolimus cream in the treatment of seborrheic dermatitis in African American adults with associated hypopigmentation.},
  author={Whitney A. High and Amit G Pandya},
  journal={Journal of the American Academy of Dermatology},
  year={2006},
  volume={54 6},
  pages={1083-8}
}
BACKGROUND African Americans with seborrheic dermatitis may manifest associated hypopigmenation. Corticosteroids and antifungals are often used for treatment, yet chronic use of corticosteroids may be associated with skin atrophy, increased intraocular pressure, or further hypopigmenation. Pimecrolimus has been used successfully in a few patients with seborrheic dermatitis. OBJECTIVES This open-label, pilot trial assessed the efficacy and tolerability of pimecrolimus in the treatment of… CONTINUE READING

Similar Papers

Loading similar papers…